Aristo Bio-Tech & Lifescience

Aristo Bio-Tech & Lifescience

121.10
+0.55
(0.46%)
Market Cap
82.10 Cr
EPS
5.97
PE Ratio
20.19
Dividend Yield
0.41 %
Industry
Chemicals
52 Week High
164.00
52 Week Low
84.55
PB Ratio
2.20
Debt to Equity
0.68
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
4,092.10
#1 62,415.30
37.54
8,322.00
18.38
#1 1,660
-10.55
50.36
722.20
54,537.80
61.35
#1 47,123.00
-19.37
820
#1 1,448.75
70.06
584.90
29,497.00
59.75
3,268.60
-17.33
506
-9.19
62.98
6,336.00
28,601.10
50.28
5,593.10
-0.37
568
49.27
63.16
1,087.10
8,198.80
27.42
4,379.40
#1 35.89
304
423.08
79.61
1,729.40
7,703.40
#1 26.68
2,071.30
2.78
297
27.97
54.84
357.40
7,139.90
31.33
2,631.40
6.54
164
-274.07
64.73
279.32
5,888.90
-
1,234.52
-15.91
-119
-455.56
59.94
10,564.00
4,505.10
31.94
1,173.00
-15.01
145
-62.59
44.01
293.40
3,927.70
282.34
440.47
-18.49
16
-112.50
43.60
Forecast
Actual
Growth Rate
Revenue Growth
12.42 %
Net Income Growth
8.33 %
Cash Flow Change
373.38 %
ROE
-1.86 %
ROCE
-12.55 %
EBITDA Margin (Avg.)
-14.73 %

Yearly Financial Results

Annual Financials
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
Revenue
58
161
272
202
201
167
166
218
245
318
0
Expenses
56
158
264
195
197
163
161
209
237
309
0
EBITDA
1
4
8
7
5
4
5
9
9
9
0
Operating Profit %
2 %
2 %
3 %
3 %
2 %
3 %
3 %
4 %
3 %
3 %
0 %
Depreciation
0
0
1
1
1
1
1
2
2
3
0
Interest
1
1
2
2
3
2
2
3
2
2
0
Profit Before Tax
1
3
6
4
1
2
2
5
5
5
0
Tax
0
1
2
1
0
0
1
1
2
1
0
Net Profit
0
2
4
3
1
1
1
4
4
4
0
EPS in ₹
3.98
18.53
37.41
5.66
2.02
2.15
2.87
6.72
5.72
5.97
0.00

Balance Sheet

Balance Sheet
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total Assets
27
87
89
91
88
81
77
100
127
141
Fixed Assets
2
2
3
8
8
12
14
16
22
24
Current Assets
25
84
81
81
77
69
63
83
105
116
Capital Work in Progress
0
0
0
2
3
0
0
1
0
0
Investments
0
0
0
0
0
0
0
0
0
47
Other Assets
25
85
86
81
77
69
63
83
106
0
Total Liabilities
27
87
89
91
88
81
77
100
127
141
Current Liabilities
24
78
70
72
65
56
51
60
84
96
Non Current Liabilities
0
5
11
7
11
12
11
10
10
8
Total Equity
3
5
9
11
12
13
15
30
34
37
Reserve & Surplus
2
4
8
6
7
8
10
23
27
31
Share Capital
1
1
1
5
5
5
5
7
7
7

Cash Flow

Cash Flow
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
0
-0
-0
0
-0
0
1
-1
Investing Activities
0
-5
-2
-2
-2
-3
-4
-7
Operating Activities
-4
1
8
1
2
7
-3
8
Financing Activities
4
4
-6
1
-1
-3
8
-2

Share Holding

% Holding
Apr 2022
Jan 2022
Mar 2023
Sept 2023
Mar 2024
Sept 2024
Mar 2025
Promoter
100.00 %
73.37 %
73.37 %
73.37 %
73.37 %
73.37 %
73.42 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
24.28 %
22.14 %
22.84 %
24.18 %
23.69 %
23.10 %
Others
0.00 %
2.35 %
4.49 %
3.78 %
2.44 %
2.94 %
3.48 %
No of Share Holders
7
1,004
660
652
742
625
512

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
29 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
29 May 2025 124.00 124.00
14 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
14 Nov 2024 159.00 137.75
20 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
20 Sept 2024 102.00 107.00
13 Sept 2024 DIVIDEND Dividend
₹ 0.40 /share
13 Sept 2024 79.25 106.25
15 Sept 2023 DIVIDEND Dividend
₹ 0.25 /share
15 Sept 2023 61.25 84.25

Technical Indicators

RSI(14)
Neutral
44.44
ATR(14)
Less Volatile
3.53
STOCH(9,6)
Oversold
7.62
STOCH RSI(14)
Oversold
10.19
MACD(12,26)
Bearish
-1.17
ADX(14)
Weak Trend
12.77
UO(9)
Bullish
26.84
ROC(12)
Downtrend And Accelerating
-13.00
WillR(14)
Oversold
-88.04